1. Home
  2. HGTY vs RAPP Comparison

HGTY vs RAPP Comparison

Compare HGTY & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HGTY
  • RAPP
  • Stock Information
  • Founded
  • HGTY 1984
  • RAPP 2022
  • Country
  • HGTY United States
  • RAPP United States
  • Employees
  • HGTY N/A
  • RAPP N/A
  • Industry
  • HGTY Specialty Insurers
  • RAPP
  • Sector
  • HGTY Finance
  • RAPP
  • Exchange
  • HGTY Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • HGTY 995.8M
  • RAPP 844.6M
  • IPO Year
  • HGTY N/A
  • RAPP 2024
  • Fundamental
  • Price
  • HGTY $10.89
  • RAPP $19.74
  • Analyst Decision
  • HGTY Hold
  • RAPP Strong Buy
  • Analyst Count
  • HGTY 2
  • RAPP 4
  • Target Price
  • HGTY $11.00
  • RAPP $37.33
  • AVG Volume (30 Days)
  • HGTY 93.9K
  • RAPP 124.8K
  • Earning Date
  • HGTY 11-07-2024
  • RAPP 02-10-2025
  • Dividend Yield
  • HGTY N/A
  • RAPP N/A
  • EPS Growth
  • HGTY N/A
  • RAPP N/A
  • EPS
  • HGTY 0.11
  • RAPP N/A
  • Revenue
  • HGTY $1,153,350,000.00
  • RAPP N/A
  • Revenue This Year
  • HGTY $21.07
  • RAPP N/A
  • Revenue Next Year
  • HGTY $14.62
  • RAPP N/A
  • P/E Ratio
  • HGTY $102.78
  • RAPP N/A
  • Revenue Growth
  • HGTY 21.13
  • RAPP N/A
  • 52 Week Low
  • HGTY $7.68
  • RAPP $16.55
  • 52 Week High
  • HGTY $12.35
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • HGTY 37.15
  • RAPP N/A
  • Support Level
  • HGTY $10.77
  • RAPP N/A
  • Resistance Level
  • HGTY $11.20
  • RAPP N/A
  • Average True Range (ATR)
  • HGTY 0.23
  • RAPP 0.00
  • MACD
  • HGTY -0.09
  • RAPP 0.00
  • Stochastic Oscillator
  • HGTY 0.80
  • RAPP 0.00

About HGTY Hagerty Inc.

Hagerty Inc is a provider of specialty automotive insurance. The company underwrites, sells, and services classic car and enthusiast vehicle insurance policies. Substantial revenue is derived from Commission and fees. Geographically it serves Europe, Canada, and the United States.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: